Retroviral vectors have been invaluable tools for studies of development in
vertebrates. Their use has been somewhat constrained, however, by the low
viral titers typically obtained with replication-incompetent vectors, parti
cularly of the avian type. We have addressed this problem in several ways.
We optimized the transient production of avian replication-incompetent viru
ses in a series of cell lines. One of the optimal cell lines was the mammal
ian line 293T, which was surprising in light of previous reports that avian
viral replication was not supported by mammalian cells. We also greatly in
creased the efficiency of viral infection. Pseudotyping with the vesicular
stomatitus virus G (VSV-G) protein led to an over 350-fold increase in the
efficiency of infection in ovo relative to infection with virus particles b
earing an avian retroviral envelope protein. To further increase the utilit
y of the system, we developed new Rous sarcoma virus (RSV)-based replicatio
n-incompetent vectors, designed to express a histochemical marker gene, hum
an placental alkaline phosphatase, as well as an additional gene. These mod
ified retroviral vectors and the VSV-G pseudotyping technique constitute si
gnificant improvements that allow for expanded use of avian replication-inc
ompetent viral vectors in ovo, (C) 1999 Academic Press.